MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
540.00
-11 (-2.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
521.70
493.80
474.20
413.10
457.70
461.70
456.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
521.70
493.80
474.20
413.10
457.70
461.70
456.60
Raw Material Cost
442.80
424.60
424.20
358.20
391.80
387.80
380.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
136.30
129.70
126.50
102.70
121.80
113.80
114.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.90
4.60
4.80
4.30
5.80
4.30
4.10
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
-14.32
-13.43
-13.13
-10.70
-12.76
-11.81
-11.88
Total Expenditure (Excl Depreciation)
442.80
424.60
424.20
358.20
391.80
387.80
380.60
Operating Profit (PBDIT) excl Other Income
78.89999999999999
69.2
50
54.900000000000006
65.9
73.89999999999999
76
Other Income
2.50
4.70
8.40
14.60
12.40
2.40
6.70
Operating Profit (PBDIT)
115.50
106.30
88.30
99.10
105.90
104.50
108.30
Interest
6.90
4.60
4.80
4.30
5.80
4.30
4.10
Exceptional Items
-4.00
-3.80
-0.80
0.00
0.00
-0.40
0.00
Gross Profit (PBDT)
78.90
69.20
50.00
54.90
65.90
73.90
76.00
Depreciation
34.10
32.40
29.90
29.60
27.60
28.20
25.60
Profit Before Tax
70.40
65.40
52.80
64.90
72.40
71.60
78.50
Tax
16.70
14.70
10.10
11.60
15.30
15.50
16.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
53.60
50.50
41.50
52.90
56.80
56.00
62.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
53.60
50.50
41.50
52.90
56.80
56.00
62.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.10
0.20
1.20
0.40
0.30
0.10
0.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
53.70
50.70
42.70
53.30
57.10
56.10
62.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.4
0.4
0.4
0.4
0.4
0.4
0.4
Reserves
1,356.40
1,306.30
1,282.00
1,193.10
1,147.50
1,093.50
1,022.90
Earnings per share (EPS)
3.57
3.37
2.8
3.54
3.8
3.76
4.18
Diluted Earnings per share
3.57
3.37
2.8
3.54
3.8
3.76
4.18
Operating Profit Margin (Excl OI)
15.12%
14.01%
10.54%
13.29%
14.4%
16.01%
16.64%
Gross Profit Margin
20.03%
19.81%
17.44%
22.88%
21.85%
21.62%
22.8%
PAT Margin
10.27%
10.23%
8.75%
12.81%
12.41%
12.13%
13.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 13.98% vs 18.54% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -5.95% vs 22.01% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 20.86% vs 9.74% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 18.97% vs 70.59% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of MedCap AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
521.70
209.16
312.54
149.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
521.70
209.16
312.54
149.43%
Raw Material Cost
442.80
92.40
350.40
379.22%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
136.30
0.00
136.30
Power Cost
0
0
0.00
Manufacturing Expenses
6.90
0.00
6.90
Selling and Distribution Expenses
0.00
69.53
-69.53
-100.00%
Other Expenses
-14.32
4.42
-18.74
-423.98%
Total Expenditure (Excl Depreciation)
442.80
206.16
236.64
114.78%
Operating Profit (PBDIT) excl Other Income
78.90
3.00
75.90
2,530.00%
Other Income
2.50
-21.71
24.21
111.52%
Operating Profit (PBDIT)
115.50
1.52
113.98
7,498.68%
Interest
6.90
0.00
6.90
Exceptional Items
-4.00
0.00
-4.00
Gross Profit (PBDT)
78.90
116.75
-37.85
-32.42%
Depreciation
34.10
20.24
13.86
68.48%
Profit Before Tax
70.40
-18.72
89.12
476.07%
Tax
16.70
1.36
15.34
1,127.94%
Provisions and contingencies
0
0
0.00
Profit After Tax
53.60
-20.08
73.68
366.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
53.60
-20.08
73.68
366.93%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.10
0.00
0.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
53.70
-20.08
73.78
367.43%
Equity Capital
0
0
0.00
Face Value
0.40
0.05
0.00
Reserves
1,356.40
4,307.45
-2,951.05
-68.51%
Earnings per share (EPS)
3.57
-0.39
3.96
1,015.38%
Diluted Earnings per share
3.57
-0.39
3.96
1,015.38%
Operating Profit Margin (Excl OI)
15.12%
1.43%
0.00
13.69%
Gross Profit Margin
20.03%
0.73%
0.00
19.30%
PAT Margin
10.27%
-9.60%
0.00
19.87%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 52.17 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 5.65% vs 4.13% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 13.98% vs 18.54% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.37 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 5.92% vs 18.74% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -5.95% vs 22.01% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.30 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 11.22% vs 27.16% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 20.86% vs 9.74% in Jun 2024

Quarterly - Interest
Interest 0.69 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 50.00% vs -4.17% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 18.97% vs 70.59% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.12%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024